Sylvie Alonso’s Group
55 posts
Sylvie Alonso’s Group
@SAlonsoGroup
Viral host-pathogen interactions and developing subunit vaccines and antivirals are what we love. Led by @NUSMedAlonsoS. Tweets by lab members!
Singapore Katılım Nisan 2023
88 Takip Edilen119 Takipçiler
Hot from the press! Fakhri’s paper on the importance of glycans on DENV NS1 is out!
Read more here embopress.org/doi/full/10.10…
English
Sylvie Alonso’s Group retweetledi
⭐Congratulations to Nicholas Cheang for winning the Best Graduate Research Publication Award 2025, and congratulations to A/Prof Sylvie Alonso for your student's achievement! 🎉✨
#PhD #Graduate #Research #GraduateResearch #nusmicroimmuno #Microbiology #Immunology #Prize #Award
English
it’s @NUSMedAlonsoS birthday 🎉🎉confetti for the aesthetic shot but note to self, don’t do it on a carpeted floor!
English
Sylvie Alonso’s Group retweetledi
1/ Increasing vaccine protection against #COVID. A/Prof @SAlonsoGroup @NUSingapore & A/Prof @LahoudMirei @MonashBDI have discovered a technique for prolonging immune response to #SARSCoV2 virus in pre-clinical models using an antibody construct. More: bit.ly/3yKN3Ek
Mireille@LahoudMirei
Delighted to celebrate our latest publication with A/Prof Sylvie Alonso @SAlonsoGroup on dendritic cell-targeting of SARS-CoV-2 antigens for durable and protective immunity. A fantastic collaboration between @MonashBDI and @NUSingapore. doi.org/10.1016/j.ymth…
English
Sylvie Alonso’s Group retweetledi
Delighted to celebrate our latest publication with A/Prof Sylvie Alonso @SAlonsoGroup on dendritic cell-targeting of SARS-CoV-2 antigens for durable and protective immunity.
A fantastic collaboration between @MonashBDI and @NUSingapore.
doi.org/10.1016/j.ymth…
English
The Clec9A team at APVIC! It was a great conference with many insightful talks by distinguished speakers :)
English
Sylvie Alonso’s Group retweetledi
📢Don't miss our BDI seminar this Fri 17 May, 12-1pm!
𝗦𝗽𝗲𝗮𝗸𝗲𝗿: A/Prof Sylvie Alonso @SAlonsoGroup @nusingapore
𝗧𝗼𝗽𝗶𝗰: A versatile & powerful dendritic cell-targeting platform to deliver vaccine antigen candidates against infectious diseases
bit.ly/3uCUMgc
English
Featuring our new publication on @MolTherapy deeply characterizing a cDC1 targeting vaxx strategy we have focused on for years, this time in SARS-CoV-2 context. Overall, our findings present its promise as a next gen pandemic response vaxx strategy Congrats to @_immunogeNIC agn!
Nicholas Cheang@_immunogeNIC
Proudly sharing that the 1st phase of my PhD work is officially published! Here, we characterized the immune response elicited by a Clec9A-cDC1 targeting SARS-CoV-2 vaccine. Thankful for @NUSMedAlonsoS guidance and all coauthors' contributions! See below our summarized findings.
English
An end to a fruitful PhD. Congrats Dr. Donald!!! 🥳🥳🥳
English
happy lunar new year from SA lab!! wishing everyone a healthy and prosperous (publications and grants 😌) year ahead
English
thanks for giving such a great talk!!!#longliveIVBDC
Nalini Puniamoorthy@Nalini_DrP
Had an engaging week at the #IVBDC2023: Shared our work on mosquito reproduction & population genomics; Was inspired by cool science & emerging technology in vector control; Had fun catching up with ex-students! Big 🙏🏾 to @SAlonsoGroup & @NUS_DBS
English
so nice to see you again @AngTopher!!!! till the next conference :)
Christopher Ang@AngTopher
Day 3 with friends from the @SAlonsoGroup! Sending ALL THE GOOD VIBES to ya’ll!
English
Let’s gooo Eunice!! another conference, another award 🎉🎉
English
2 presentations in a month, this time round at #IVBDC23. @NUSMedAlonsoS presenting the recent work on DENV NS1 done by Dr Fakhri :)
English
Featuring the boss @NUSMedAlonsoS presenting a translational and exciting story about the lab's cDC1 targeting vaccine research at the annual SgSI symposium. 🎉🎉🎉
English